Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Motor Neurons | 16 | 2012 | 65 | 2.740 |
Why?
|
| Amyotrophic Lateral Sclerosis | 10 | 2019 | 71 | 2.690 |
Why?
|
| Immunity | 2 | 2018 | 22 | 1.140 |
Why?
|
| Spinal Cord | 11 | 2012 | 150 | 1.000 |
Why?
|
| HSP70 Heat-Shock Proteins | 4 | 2014 | 32 | 0.870 |
Why?
|
| Astrocytes | 4 | 2012 | 64 | 0.850 |
Why?
|
| Muscle, Skeletal | 7 | 2018 | 568 | 0.760 |
Why?
|
| Apoptosis | 7 | 2013 | 400 | 0.710 |
Why?
|
| Animals | 31 | 2019 | 8544 | 0.700 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2019 | 16 | 0.620 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 14 | 0.610 |
Why?
|
| Heat-Shock Proteins | 1 | 2019 | 44 | 0.600 |
Why?
|
| Chick Embryo | 12 | 2012 | 76 | 0.580 |
Why?
|
| Immunomodulation | 1 | 2018 | 32 | 0.570 |
Why?
|
| Interleukin-6 | 1 | 2019 | 257 | 0.570 |
Why?
|
| Disease Progression | 1 | 2019 | 633 | 0.520 |
Why?
|
| Inflammation | 1 | 2018 | 557 | 0.440 |
Why?
|
| Cell Survival | 6 | 2010 | 304 | 0.420 |
Why?
|
| Cysteine Endopeptidases | 3 | 1998 | 9 | 0.390 |
Why?
|
| Protein Precursors | 1 | 2012 | 27 | 0.370 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2012 | 40 | 0.360 |
Why?
|
| Neuromuscular Junction | 6 | 2018 | 76 | 0.350 |
Why?
|
| Stilbenes | 1 | 2010 | 22 | 0.330 |
Why?
|
| Cell Separation | 1 | 2011 | 93 | 0.320 |
Why?
|
| Oxidative Stress | 2 | 2008 | 265 | 0.300 |
Why?
|
| Axonal Transport | 1 | 2008 | 7 | 0.280 |
Why?
|
| Synaptic Vesicles | 1 | 2008 | 8 | 0.280 |
Why?
|
| HSC70 Heat-Shock Proteins | 1 | 2008 | 4 | 0.280 |
Why?
|
| Phosphotransferases | 1 | 2007 | 5 | 0.270 |
Why?
|
| Neuroprotective Agents | 1 | 2007 | 34 | 0.270 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 1118 | 0.260 |
Why?
|
| Macrophages | 3 | 1995 | 216 | 0.260 |
Why?
|
| Mice | 10 | 2017 | 2691 | 0.250 |
Why?
|
| Hyperthermia, Induced | 2 | 2014 | 245 | 0.250 |
Why?
|
| Cells, Cultured | 7 | 2013 | 887 | 0.240 |
Why?
|
| Caspases | 3 | 2013 | 44 | 0.240 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 177 | 0.240 |
Why?
|
| Extracellular Fluid | 1 | 2005 | 17 | 0.230 |
Why?
|
| Signal Transduction | 2 | 2007 | 765 | 0.210 |
Why?
|
| Superoxide Dismutase | 3 | 2010 | 48 | 0.210 |
Why?
|
| Cell Death | 6 | 2006 | 84 | 0.210 |
Why?
|
| Cyclin E | 1 | 2003 | 5 | 0.210 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2003 | 8 | 0.200 |
Why?
|
| Cell Cycle | 1 | 2003 | 77 | 0.200 |
Why?
|
| Neurons, Afferent | 1 | 2003 | 70 | 0.200 |
Why?
|
| Humans | 14 | 2019 | 34474 | 0.190 |
Why?
|
| Neuroglia | 2 | 1991 | 32 | 0.180 |
Why?
|
| Case-Control Studies | 2 | 2019 | 924 | 0.160 |
Why?
|
| Nerve Growth Factors | 2 | 2005 | 16 | 0.160 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 627 | 0.160 |
Why?
|
| Cell Communication | 2 | 2012 | 42 | 0.150 |
Why?
|
| Mutation | 3 | 2016 | 529 | 0.150 |
Why?
|
| Tracheostomy | 1 | 2019 | 29 | 0.140 |
Why?
|
| Muscle Denervation | 2 | 2017 | 31 | 0.140 |
Why?
|
| Enzyme Precursors | 1 | 1998 | 2 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2013 | 755 | 0.140 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 105 | 0.140 |
Why?
|
| Neurons | 3 | 2016 | 491 | 0.140 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2017 | 30 | 0.130 |
Why?
|
| Caspase 3 | 2 | 2012 | 43 | 0.130 |
Why?
|
| Brain | 3 | 2016 | 1031 | 0.130 |
Why?
|
| Ultrasonography | 1 | 2018 | 417 | 0.120 |
Why?
|
| Time Factors | 4 | 2013 | 2352 | 0.120 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2016 | 2 | 0.120 |
Why?
|
| Fluorodeoxyuridylate | 1 | 2016 | 23 | 0.120 |
Why?
|
| Troponin T | 1 | 2017 | 98 | 0.120 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1995 | 7 | 0.120 |
Why?
|
| Receptors, Opioid | 1 | 1995 | 14 | 0.110 |
Why?
|
| Chemotaxis | 1 | 1995 | 23 | 0.110 |
Why?
|
| Nanoparticles | 1 | 2016 | 57 | 0.110 |
Why?
|
| Cohort Studies | 1 | 2019 | 1910 | 0.110 |
Why?
|
| Antioxidants | 1 | 2016 | 126 | 0.110 |
Why?
|
| Mitochondria | 2 | 2015 | 218 | 0.110 |
Why?
|
| Brain Injuries | 1 | 1995 | 94 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2016 | 270 | 0.110 |
Why?
|
| Physical Endurance | 1 | 2014 | 42 | 0.110 |
Why?
|
| Female | 8 | 2019 | 21490 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2012 | 73 | 0.100 |
Why?
|
| Muscle Strength | 1 | 2014 | 157 | 0.100 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2012 | 115 | 0.100 |
Why?
|
| Polymers | 1 | 2013 | 71 | 0.100 |
Why?
|
| Male | 7 | 2019 | 20697 | 0.100 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 56 | 0.100 |
Why?
|
| Caspase 7 | 1 | 2012 | 3 | 0.090 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2012 | 6 | 0.090 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2012 | 14 | 0.090 |
Why?
|
| Chickens | 1 | 2012 | 40 | 0.090 |
Why?
|
| African Americans | 1 | 2019 | 1435 | 0.090 |
Why?
|
| Glioblastoma | 1 | 2013 | 161 | 0.090 |
Why?
|
| Adult | 3 | 2019 | 10015 | 0.090 |
Why?
|
| Aging | 2 | 2017 | 1010 | 0.090 |
Why?
|
| Aged | 3 | 2019 | 10998 | 0.090 |
Why?
|
| Geniculate Bodies | 1 | 1991 | 24 | 0.090 |
Why?
|
| Visual Cortex | 1 | 1991 | 47 | 0.090 |
Why?
|
| Insulin Resistance | 1 | 2014 | 488 | 0.090 |
Why?
|
| Dissection | 1 | 2011 | 18 | 0.080 |
Why?
|
| Motor Neuron Disease | 1 | 2010 | 4 | 0.080 |
Why?
|
| Immunoglobulins | 1 | 2010 | 15 | 0.080 |
Why?
|
| Immunohistochemistry | 4 | 2005 | 593 | 0.080 |
Why?
|
| Information Services | 1 | 2010 | 15 | 0.080 |
Why?
|
| Middle Aged | 3 | 2019 | 12703 | 0.080 |
Why?
|
| Biological Specimen Banks | 1 | 2010 | 11 | 0.080 |
Why?
|
| Acetylation | 1 | 2010 | 17 | 0.080 |
Why?
|
| Longevity | 1 | 2010 | 24 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2010 | 508 | 0.080 |
Why?
|
| Sirtuin 1 | 1 | 2010 | 40 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 80 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2007 | 82 | 0.080 |
Why?
|
| Age Factors | 2 | 2017 | 1261 | 0.080 |
Why?
|
| Psychomotor Performance | 1 | 2010 | 116 | 0.080 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2006 | 15 | 0.080 |
Why?
|
| Neoplasms | 1 | 2016 | 791 | 0.070 |
Why?
|
| Body Weight | 1 | 2010 | 343 | 0.070 |
Why?
|
| Microscopy, Interference | 1 | 2008 | 2 | 0.070 |
Why?
|
| Motion Perception | 1 | 2008 | 7 | 0.070 |
Why?
|
| Viscosity | 1 | 2008 | 26 | 0.070 |
Why?
|
| Neurites | 1 | 2008 | 11 | 0.070 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 649 | 0.070 |
Why?
|
| Riluzole | 1 | 2007 | 5 | 0.070 |
Why?
|
| Diet | 1 | 2010 | 418 | 0.070 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2007 | 4 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2008 | 90 | 0.070 |
Why?
|
| Oligopeptides | 1 | 2008 | 55 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 118 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 38 | 0.070 |
Why?
|
| Hindlimb | 1 | 2007 | 55 | 0.070 |
Why?
|
| Kinetics | 1 | 2008 | 259 | 0.070 |
Why?
|
| Hydrogen Peroxide | 1 | 2008 | 87 | 0.070 |
Why?
|
| Fever | 1 | 2007 | 63 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 185 | 0.060 |
Why?
|
| Culture Media, Conditioned | 1 | 2007 | 53 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2007 | 328 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 1998 | 319 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 259 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2006 | 68 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 1998 | 389 | 0.060 |
Why?
|
| Movement | 1 | 2006 | 62 | 0.060 |
Why?
|
| Behavior, Animal | 1 | 2007 | 303 | 0.060 |
Why?
|
| Calcium | 1 | 2008 | 343 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 834 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2005 | 8 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2005 | 87 | 0.060 |
Why?
|
| Motor Activity | 1 | 2007 | 356 | 0.060 |
Why?
|
| Rats | 3 | 1995 | 1946 | 0.050 |
Why?
|
| Growth Inhibitors | 1 | 2003 | 10 | 0.050 |
Why?
|
| Cerebral Cortex | 2 | 2013 | 146 | 0.050 |
Why?
|
| Animals, Newborn | 2 | 1995 | 143 | 0.050 |
Why?
|
| Genes, bcl-2 | 1 | 2002 | 1 | 0.050 |
Why?
|
| Muscle Contraction | 2 | 2017 | 183 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 526 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 1991 | 270 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2018 | 43 | 0.040 |
Why?
|
| Diaphragm | 1 | 2018 | 39 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 77 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 1998 | 91 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit | 1 | 2017 | 9 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 103 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 583 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 1998 | 545 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 925 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2017 | 125 | 0.030 |
Why?
|
| Action Potentials | 1 | 2017 | 220 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2016 | 72 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2016 | 67 | 0.030 |
Why?
|
| Microvessels | 1 | 2016 | 31 | 0.030 |
Why?
|
| Tissue Extracts | 1 | 1995 | 2 | 0.030 |
Why?
|
| Caspase 1 | 1 | 1995 | 7 | 0.030 |
Why?
|
| Morphogenesis | 1 | 1995 | 7 | 0.030 |
Why?
|
| Chemotactic Factors | 1 | 1995 | 4 | 0.030 |
Why?
|
| Toes | 1 | 1995 | 18 | 0.030 |
Why?
|
| Opioid Peptides | 1 | 1995 | 14 | 0.030 |
Why?
|
| Solubility | 1 | 1995 | 43 | 0.030 |
Why?
|
| Nerve Degeneration | 1 | 1995 | 17 | 0.030 |
Why?
|
| Thalamus | 1 | 1995 | 39 | 0.030 |
Why?
|
| Proteins | 1 | 2016 | 155 | 0.030 |
Why?
|
| European Continental Ancestry Group | 1 | 2019 | 1176 | 0.030 |
Why?
|
| Diterpenes | 1 | 2014 | 23 | 0.030 |
Why?
|
| Random Allocation | 1 | 2014 | 257 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2013 | 50 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 118 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2013 | 86 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 2366 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2013 | 290 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2013 | 112 | 0.020 |
Why?
|
| Body Composition | 1 | 2014 | 415 | 0.020 |
Why?
|
| Phagocytes | 1 | 1991 | 6 | 0.020 |
Why?
|
| Antigens | 1 | 1991 | 36 | 0.020 |
Why?
|
| Pregnancy | 1 | 1995 | 1069 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 2825 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 772 | 0.020 |
Why?
|
| Semaphorins | 1 | 2010 | 2 | 0.020 |
Why?
|
| Growth Cones | 1 | 2010 | 3 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 11 | 0.020 |
Why?
|
| Information Management | 1 | 2010 | 2 | 0.020 |
Why?
|
| Tubulin | 1 | 2010 | 12 | 0.020 |
Why?
|
| Computer Security | 1 | 2010 | 9 | 0.020 |
Why?
|
| Serum | 1 | 2010 | 18 | 0.020 |
Why?
|
| Massachusetts | 1 | 2010 | 29 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 4150 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 30 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2010 | 33 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 138 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 3812 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2010 | 55 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2010 | 111 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 165 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 216 | 0.020 |
Why?
|
| Research | 1 | 2010 | 88 | 0.020 |
Why?
|
| Ganglia, Spinal | 1 | 2010 | 72 | 0.020 |
Why?
|
| Stroke | 1 | 2016 | 700 | 0.020 |
Why?
|
| Proteomics | 1 | 2010 | 106 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2010 | 378 | 0.020 |
Why?
|
| Internet | 1 | 2010 | 207 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 325 | 0.020 |
Why?
|
| Vacuoles | 1 | 2006 | 3 | 0.020 |
Why?
|
| Gliosis | 1 | 2006 | 6 | 0.020 |
Why?
|
| Schwann Cells | 1 | 2006 | 6 | 0.020 |
Why?
|
| Denervation | 1 | 2006 | 13 | 0.020 |
Why?
|
| Spinal Nerve Roots | 1 | 2006 | 14 | 0.020 |
Why?
|
| Demyelinating Diseases | 1 | 2006 | 10 | 0.020 |
Why?
|
| Axons | 1 | 2006 | 36 | 0.020 |
Why?
|
| Presynaptic Terminals | 1 | 2006 | 40 | 0.020 |
Why?
|
| Thymidine | 1 | 2005 | 5 | 0.010 |
Why?
|
| Tetanus Toxin | 1 | 2005 | 6 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2005 | 43 | 0.010 |
Why?
|
| Limb Buds | 1 | 2005 | 1 | 0.010 |
Why?
|
| Cell Count | 1 | 2005 | 55 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 124 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2005 | 264 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2005 | 429 | 0.010 |
Why?
|
| Cervical Vertebrae | 1 | 2002 | 54 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2002 | 127 | 0.010 |
Why?
|